Comerica Bank’s Day One Biopharmaceuticals DAWN Stock Holding History

Comerica Bank’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$7.23K	Sell	776 -294	-27%	-$2.46K	﹤0.01%	3319
2025 Q3	$7.54K	Buy	1,070 +286	+36%	+$1.97K	﹤0.01%	3316
2025 Q2	$5.1K	Sell	784 -166	-17%	-$1.14K	﹤0.01%	3364
2025 Q1	$7.53K	Buy	950 +605	+175%	+$6.52K	﹤0.01%	3237
2024 Q4	$4.37K	Hold	345	–	–	﹤0.01%	3340
2024 Q3	$4.8K	Buy	345 +97	+39%	+$1.38K	﹤0.01%	3344
2024 Q2	$3.42K	Buy	248 +42	+20%	+$615	﹤0.01%	3370
2024 Q1	$3.4K	Hold	206	–	–	﹤0.01%	3419
2023 Q4	$3.01K	Hold	206	–	–	﹤0.01%	3430
2023 Q3	$2.53K	Buy	+206	New	+$2.69K	﹤0.01%	3525

Other funds holding DAWN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Comerica Bank's DAWN Position: Q4 2025 in Review

Comerica Bank reduced its Day One Biopharmaceuticals (DAWN) stake by 27% in Q4 2025, selling an estimated $2.46K and leaving 776 shares worth $7.23K. The position accounts for ﹤0.01% of the portfolio, ranked #3319.

Comerica Bank first reported a position in DAWN in Q3 2023 and has held it in 10 quarters since. The position peaked at $7.54K in Q3 2025. 183 funds tracked by Wall St. Rank hold DAWN as of Q4 2025.

Comerica Bank held 776 shares of Day One Biopharmaceuticals worth $7.23K as of Q4 2025.
Comerica Bank sold 294 Day One Biopharmaceuticals shares in Q4 2025, an estimated $2.46K.
Day One Biopharmaceuticals made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #3319 holding.
Comerica Bank first reported a position in Day One Biopharmaceuticals in Q3 2023 and has held it in 10 quarters since.
Comerica Bank's Day One Biopharmaceuticals position peaked at $7.54K in Q3 2025.
183 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.